Ohta, Yumi
Kazuki, Kanako
Abe, Satoshi
Oshimura, Mitsuo
Kobayashi, Kaoru
Kazuki, Yasuhiro http://orcid.org/0000-0003-4818-4710
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18am0301009)
Article History
Received: 13 April 2020
Accepted: 10 August 2020
First Online: 20 August 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Dr. Mitsuo Oshimura is CEO and a shareholder of Trans Chromosomics Inc., Dr. Satoshi Abe is a member of Trans Chromosomics Inc., and the other authors declare no conflict of interest.